SLC1A2 and neoplasm: Selective inhibition of ANLN may be a new strategy for the treatment of lung cancer47.Solute carrier family 2 member 1 (SLC2A1), also known as glucose transporter 1 (GLUT1), is a glucose transporter coding gene related to the growth and proliferation of tumor cells48.